CRISPR Therapeutics (CRSP)
(Delayed Data from NSDQ)
$56.16 USD
+0.60 (1.08%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $56.95 +0.79 (1.41%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-1.63 | -4.79% |
Earnings Summary
For their last quarter, CRISPR Therapeutics (CRSP) reported earnings of $1.10 per share, beating the Zacks Consensus Estimate of $-0.40 per share. This reflects a positive earnings surprise of 375.00%. Look out for CRSP's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$1.63 per share, reflecting a year-over-year decrease of 143.28%.
Earnings History
Price & Consensus
Zacks News for CRSP
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know
CRSP: What are Zacks experts saying now?
Zacks Private Portfolio Services